Abstract: A method reduces oxidative stress or endothelial dysfunction in a mammal. The method includes administering to the mammal a compound of formula I: or an enantiomer, diastereomer, racemate, or a pharmaceutically acceptable salt of the compound.
Type:
Grant
Filed:
March 27, 2017
Date of Patent:
June 19, 2018
Assignee:
Salzman Group, Inc.
Inventors:
Andrew Lurie Salzman, Prakash Jagtap, Garry John Southan
© 2024 Justia
